Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Cell Death & Disease
|
March 1, 2014
Necroptosis induced by RIPK3 requires MLKL but not Drp1
D M Moujalled, W D Cook, J M Murphy, et al.
Cell Death & Disease
|
January 19, 2013
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
D M Moujalled, W D Cook, T Okamoto, et al.
Cell Death and Differentiation
|
June 7, 2014
RIPK1- and RIPK3-induced cell death mode is determined by target availability
W D Cook, D M Moujalled, T J Ralph, et al.
Cell Death and Differentiation
|
November 19, 2011
In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it
D M Moujalled, W D Cook, J M Lluis, et al.
Leukemia
|
July 29, 2017
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
T-C Teh, N-Y Nguyen, D M Moujalled, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Cell Death & Disease
|
March 1, 2014
Necroptosis induced by RIPK3 requires MLKL but not Drp1
D M Moujalled, W D Cook, J M Murphy, et al.
Cell Death & Disease
|
January 19, 2013
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
D M Moujalled, W D Cook, T Okamoto, et al.
Cell Death and Differentiation
|
June 7, 2014
RIPK1- and RIPK3-induced cell death mode is determined by target availability
W D Cook, D M Moujalled, T J Ralph, et al.
Cell Death and Differentiation
|
November 19, 2011
In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it
D M Moujalled, W D Cook, J M Lluis, et al.
Leukemia
|
July 29, 2017
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
T-C Teh, N-Y Nguyen, D M Moujalled, et al.
Page
of 1